Overview

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This pilot proposal will test the hypothesis that altered cerebral vessel reactivity and cerebral hypoperfusion (decreased blood flow to the brain) is a core mechanism underlying the relationship between vascular disease and depression in older adults. The long-term objective of this line of research is to: A) determine the relationship between vascular reactivity, cerebral hypoperfusion and the persistence of late-life depression and B) determine if improving cerebral perfusion with angiotensin receptor blockers (ARBs) improves depression outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University
Treatments:
Candesartan
Candesartan cilexetil
Sertraline